# LSK Investment

> LSK Investment is a VC fund in Seoul backing Biotechnology and Medical. See 41 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 41
- Last investment: Oct 2025
- Lead investor: 7%
- Last updated: Aug 2026
- Website: http://www.lski.co.kr

LSK Investment is a Korean venture capital firm that provides long-term capital and management support to venture enterprises. The firm was founded in 2016 and is based in Seoul, Korea.

## Contacts

5 contacts available for LSK Investment. Shizune tracks 1 team members at LSK Investment. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lsk-investment?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.6M–$14M |
| Series B | $7.4M–$16M |
| Series C | $3.2M–$46M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 21 | 51% |
| Medical | 17 | 41% |
| Health Care | 14 | 34% |
| Pharmaceutical | 10 | 24% |
| Biopharma | 9 | 22% |

35 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 16 | 39% |
| Series B | 12 | 29% |
| Series C | 5 | 12% |
| Seed | 3 | 7% |
| Funding Round | 2 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 34 | 83% |
| United States | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Lee Myung-kwon | Managing Director | 1 | https://shizune.co/investors/profile/lee-myung-kwon |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| IMBiologics | IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules. | $29.5M | Series C | Oct 14, 2025 |  |
| MBD | MBD is a biotechnology company that specializes in 3D cell culture platforms. | $11.9M | Series C | Aug 14, 2025 |  |
| Trioar | Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs. | $16.2M | Series B | Jul 17, 2025 |  |
| Medi Builder | Medi Builder operates as a Medical Accelerator Management Services Organization (MSO), functioning as a non-hospital business agency similar to its subsidiaries, the special-purpose medical companies (SMCs). However, there are significant differences between SMCs and the MSO in terms of capacity for acceleration, growth potential, and exit plans. | $10.3M | Series B | Jun 05, 2025 |  |
| NeuroXT | NeuroXT develops software for precision diagnosis that predicts molecular pathology values. It uses magnetic resonance imaging (MRI) data to assess the effects and adverse reactions of specific drugs, supporting evaluation of patient suitability. The system applies image analysis methods to inform treatment decisions for degenerative braindiseases. |  | Series A | Mar 10, 2025 |  |
| Special Touch Nursing Services | Special Touch Nursing Services provides in-home nursing care, including health assessments, medication management, and non-medical assistance such as personal care, transportation, and household support. The company also offers licensed case management services to assess needs, coordinate care plans, and advocate on behalf of clients and families.Services are delivered by registered nurses, licensed social workers, nursing assistants, and caregivers to support independence and well-being for seniors and disabled individuals. | $1.3M | Seed | Nov 20, 2024 |  |
| Avelos Therapeutics | Avelos Therapeutics is a precision medicine company in the clinical stage that finds, creates, and sells targeted therapeutics. | $12.4M | Series B | May 02, 2024 |  |
| Refeely | Refeely is a refill-focused packaging company that offers B2B packaging solutions using refillable paper cartons for products. The company develops eco-friendly refill products and paper-based packaging system. | $742.8K | Seed | Mar 29, 2024 |  |
| Surginex | Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services. | $6.3M | Series B | Mar 28, 2024 |  |
| Surginex | Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services. | $6.3M |  | Mar 27, 2024 |  |

10 of 41 investments shown.

## Co-investors
- [Hana Ventures](https://shizune.co/investors/profile/hana-ventures) — VC Fund, 7 deals together
- [Shinhan Venture Investment](https://shizune.co/investors/profile/shinhan-venture-investment) — VC Fund, 6 deals together
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 5 deals together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 5 deals together
- [Partners Investment](https://shizune.co/investors/profile/partners-investment) — VC Fund, 5 deals together
- [UTC Investment Co.](https://shizune.co/investors/profile/utc-investment-co) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Medical VC Funds in South Korea](https://shizune.co/investors/medical-vc-funds-south-korea)
- [Biotechnology Investors in South Korea](https://shizune.co/investors/biotechnology-investors-south-korea)

## FAQ

### What does LSK Investment invest in?

LSK Investment invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 41 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is LSK Investment's check size?

LSK Investment typically joins rounds of $1.6M–$14M at Series A, $7.4M–$16M at Series B and $3.2M–$46M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LSK Investment participates in.

### How do I contact LSK Investment?

Public channels for LSK Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LSK Investment?

The team at LSK Investment includes Lee Myung-kwon (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co